Telehealth for Hepatitis C Care in the DAA Era; Ensuring Everyone Can Access a Cure
نویسندگان
چکیده
منابع مشابه
Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection
Background Direct-acting antivirals (DAA) as curative therapy for hepatitis C virus (HCV) infection offer >95% sustained virologic response (SVR), including in patients with human immunodeficiency virus (HIV) infection. Despite improved safety and efficacy of HCV treatment, challenges remain, including drug-drug interactions between DAA and antiretroviral therapy (ART) and restrictions on acces...
متن کامل“Sell an Ox” - The Price of Cure for Hepatitis C in Two Countries
Chronic hepatitis C virus (HCV) infection, associated with severe liver disease and cancer, affects 70 million people worldwide. New treatments with direct-acting-antivirals offer cure for about 95% of affected individuals; however, treatment costs may be prohibitive in both the poorest and richest nations. Opting for cure may require sacrificing essential household ass...
متن کاملBarriers to care for chronic hepatitis C in the direct-acting antiviral era: a single-centre experience
Background Cure rates for chronic hepatitis C have improved dramatically with direct-acting antivirals (DAAs), but treatment barriers remain. We aimed to compare treatment initiation rates and barriers across both interferon-based and DAA-based eras. Methods We conducted a retrospective cohort study of all patients with chronic hepatitis C seen at an academic hepatology clinic from 1999 to 20...
متن کاملHCV cure for everyone or which challenges remain?
Following the approval of the first HCV direct-acting antiviral (DAA) in 2011, an unforeseen revolution in the treatment of chronic hepatitis C has taken place. In 2015 several all-oral DAA regimens, combining agents from different families (NS5B nucleotide inhibitors, NS5B non-nucleoside inhibitors, NS5A replication complex inhibitors and NS3/4A protease inhibitors) are now commercially availa...
متن کاملThe New Era of Interferon-Free Treatment of Chronic Hepatitis C
BACKGROUND Within the development and approval of several new direct-acting antivirals (DAA) against hepatitis C virus (HCV), a new era of hepatitis C therapy has begun. Even more treatment options are likely to become available during the next 1-2 years. METHODS A summary of the current phase II and III trials investigating DAA and a review of the recent HCV guidelines was conducted. RESUL...
متن کامل